Akoya Biosciences SG&A Expense (Quarterly) Insights

Akoya Biosciences Inc (AKYA)

3.81 0.00 (0.00%) USD | NASDAQ | Apr 24, 16:00

3.815 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	18.90M
September 30, 2023	19.02M
June 30, 2023	22.71M
March 31, 2023	21.76M
December 31, 2022	20.95M
September 30, 2022	19.92M
June 30, 2022	20.59M
March 31, 2022	18.19M

Date	Value
December 31, 2021	19.05M
September 30, 2021	13.72M
June 30, 2021	10.07M
March 31, 2021	8.179M
December 31, 2020	6.816M
September 30, 2020	5.712M
June 30, 2020	5.105M
March 31, 2020	6.349M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.105M

Minimum

Jun 2020

22.71M

Maximum

Jun 2023

14.81M

Average

18.55M

Median

SG&A Expense (Quarterly) Benchmarks